We need your input! There are various ways that you can provide us with your feedback throughout the review process. See our feedback opportunities below to determine when the opportunity is available and the key actions to take in order to participate.
Stakeholder Interviews
Our Qualitative Research Team conducts in-depth telephone interviews and/or surveys with key stakeholders, including (but not limited to) patients, prescribers and pharmacists.
- Time Period
- CLOSED: We are no longer recruiting interview participants.
- Key Documents/Information Required to Provide Input
- CLOSED: We are no longer recruiting interview participants
Evidence Submission Packages
In order to ensure that all relevant research, whether published or not, is available for inclusion in the final report, submissions are invited from drug manufacturers, professional societies and other interested groups. We ask that these groups identify any evidence relevant to the review that is known to them, including clinical trials, follow-up studies and evidence from disease registries. This may also include relevant evidence that is unpublished.
- Time Period
- CLOSED: We are no longer accepting evidence submission packages
Stakeholder Review of Comprehensive Research Plan
Stakeholders are invited to provide feedback on research plans in order to identify key considerations for the conduct of each research study within the drug class review.
- Time Period
- CLOSED: We are no longer accepting comments on our comprehensive research plans.
- Key Documents
Stakeholder Review of Draft Reports
Stakeholders are invited to comment on the draft reports of findings developed by each research team. Comments may be considered when finalizing the reports prior to submitting these to the Ministry of Health and Long-Term Care.
- Time Period
- CLOSED: We are no longer accepting comments on our draft reports. Final reports to be posted in August/September 2015
Any questions? Contact us at info@odprn.ca.